HIMS Today - Jul 15: New Partners Fuel Growth
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
HIMS Today - Jul 15: New Partners Fuel Growth
-
ナレーター：
-
著者：
So, what went down? HIMS had a pretty solid day, bouncing back with some nice gains. You know how it is—some days you're riding high, and other days, it feels like you’re just trying to keep your head above water. Today, though? It was all about those gains.
Now, why did it happen? Well, there’s a lot of buzz around Hims right now. They’ve got eight new partners on board, which is fueling their push to create this all-in-one health platform. Sounds ambitious, right? But hey, if you’re gonna dream, dream big! Also, their CEO is eyeing a heart attack prediction firm, which he thinks has "unreal" value. That’s got investors feeling optimistic. On top of that, they’re gearing up for a call on August 10 to discuss their latest health platform results. So, there’s definitely a lot of action happening behind the scenes.
But it’s not all sunshine and rainbows. There’s some FDA scrutiny on their peptide products, and Citi just dropped a note saying there’s a “big caveat” to Amazon’s GLP-1 push that could impact HIMS. So, while things are looking good now, there are some potential bumps in the road to keep an eye on.
So, what’s the takeaway? Hims & Hers is in the spotlight with some new partnerships and ambitious plans, but they’ve got some challenges ahead too. Just a friendly reminder that the market can be wild, so always keep that in mind!
Alright, that’s a wrap for today! Just here to keep you in the loop, so remember, this isn’t financial advice—just some friendly info. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません